Clinical Trial Update: A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients [Phase 3]

View source ↗

Summary

A Phase III trial evaluating chemotherapy and immunotherapy for advanced nasopharyngeal carcinoma has completed recruitment with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Tessa Therapeutics | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2023-06-28